-
EP1689877
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1689877
| EP1689877 - FUSION PROTEINS AND METHODS OF CLEAVAGE OF SUCH PROTEINS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.11.2007 Database last updated on 21.03.2026 | Most recent event Tooltip | 09.11.2007 | Application deemed to be withdrawn | published on 12.12.2007 [2007/50] | Applicant(s) | For all designated states NOVO NORDISK A/S Novo Allé 2880 Bagsværd / DK | For all designated states The Burnham Institute 10901 North Torrey Pines Road La Jolla, CA 92037 / US | [N/P] |
| Former [2006/33] | For all designated states NOVO NORDISK A/S Novo Allé 2880 Bagsvaerd / DK | ||
| For all designated states The Burnham Institute 10901 North Torrey Pines Road La Jolla, CA 92037 / US | Inventor(s) | 01 /
STENNICKE, Henning Ralf Nordskr nten 59 DK-2980 Kokkedal / DK | 02 /
IVERSEN, Lars Fogh Gr sdammen 10 DK-2840 Holte / DK | 03 /
SALVESEN, Guy S. 1936 Circle Park Lane Encinitas, California 92024 / US | [2006/33] | Representative(s) | Winther, Kamilla Novo Nordisk A/S Corporate Patents Novo Allé 2880 Bagsvaerd / DK | [N/P] |
| Former [2006/33] | Winther, Kamilla Novo Nordisk A/S, Corporate Patents, Novo Allé 2880 Bagsvaerd / DK | Application number, filing date | 04797476.1 | 24.11.2004 | [2006/33] | WO2004DK00815 | Priority number, date | DK20030001729 | 24.11.2003 Original published format: DK 200301729 | [2006/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005049847 | Date: | 02.06.2005 | Language: | EN | [2005/22] | Type: | A1 Application with search report | No.: | EP1689877 | Date: | 16.08.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.06.2005 takes the place of the publication of the European patent application. | [2006/33] | Search report(s) | International search report - published on: | EP | 02.06.2005 | Classification | IPC: | C12P21/06, C07K14/54 | [2006/33] | CPC: |
C12N9/6467 (EP,US);
C07K14/475 (EP,US);
C07K14/54 (EP,US);
C07K14/745 (EP,US);
C12N9/6472 (EP,US);
C12P21/06 (EP,US);
C07K2319/50 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/33] | Extension states | AL | Not yet paid | HR | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | FUSIONSPROTEINE UND VERFAHREN ZUR SPALTUNG SOLCHER PROTEINE | [2006/33] | English: | FUSION PROTEINS AND METHODS OF CLEAVAGE OF SUCH PROTEINS | [2006/33] | French: | PROTEINES DE FUSION ET METHODES DE CLIVAGE DE CES PROTEINES | [2006/33] | Entry into regional phase | 26.06.2006 | National basic fee paid | 26.06.2006 | Designation fee(s) paid | 26.06.2006 | Examination fee paid | Examination procedure | 26.06.2006 | Examination requested [2006/33] | 11.12.2006 | Despatch of a communication from the examining division (Time limit: M06) | 22.06.2007 | Application deemed to be withdrawn, date of legal effect [2007/50] | 26.07.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/50] | Fees paid | Renewal fee | 30.11.2006 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [PY] WO2004074488 (BIOTECNOL SA et al.) [PY] * page 23, line 15 - line 30 * | [E] WO0061768 (YEDA RES & DEV et al.) [E] * figure 1; example 2 * * page 6, line 33 * | [PX] WO0198455 (SMITHKLINE BEECHAM CORP et al.) | [PX] WO0120989 (MAYO FOUNDATION et al.) [PX] 1-16 * figures 3a,3b; examples 1-5 * | [X] WO0206458 (CHEMICON INTERNATIONAL INC et al.) [X] 1-16 * examples 8-11 * * page 3, line 23 - line 31 * * figure 8 * | [X] WO0073437 (MERCK FROSST CANADA INC et al.) [X] 1-16 * figure 10; examples 5-16 * | [PX] MERTENS N ET AL: "NEW STRATEGIES IN POLYPEPTIDE AND ANTIBODY SYNTHESIS: AN OVERVIEW", CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, LIEBERT, US, vol. 19, no. 1, February 2004 (2004-02-01), pages 99 - 109, XP008032571 DOI: http://dx.doi.org/10.1089/108497804773391748 | [X] STENNICKE ET AL: "Biochemical characteristics of caspases-3, -6, -7 and -8", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 272, no. 41, 1997, pages 25719 - 25723, XP002146144, ISSN: 0021-9258 DOI: http://dx.doi.org/10.1074/jbc.272.41.25719 |